about
Secondary prevention of coronary heart disease in older British men: extent of inequalities before and after implementation of the National Service FrameworkLong-term interleukin-6 levels and subsequent risk of coronary heart disease: two new prospective studies and a systematic reviewCarboxyhaemoglobin levels and their determinants in older British menCan metabolic syndrome usefully predict cardiovascular disease and diabetes? Outcome data from two prospective studies.Socioeconomic inequalities in coronary heart disease risk in older age: contribution of established and novel coronary risk factors.Circulating inflammatory and hemostatic biomarkers are associated with risk of myocardial infarction and coronary death, but not angina pectoris, in older men.Prospective study of matrix metalloproteinase-9 and risk of myocardial infarction and stroke in older men and women.Social class differences in secular trends in established coronary risk factors over 20 years: a cohort study of British men from 1978-80 to 1998-2000Is the recent rise in type 2 diabetes incidence from 1984 to 2007 explained by the trend in increasing BMI?: evidence from a prospective study of British menHow much of the recent decline in the incidence of myocardial infarction in British men can be explained by changes in cardiovascular risk factors? Evidence from a prospective population-based study.Secondary prevention of coronary heart disease in older patients after the national service framework: population based study.Sarcopenic obesity and risk of cardiovascular disease and mortality: a population-based cohort study of older men.Physical activity in older men: longitudinal associations with inflammatory and hemostatic biomarkers, N-terminal pro-brain natriuretic peptide, and onset of coronary heart disease and mortality.Interleukin 18 and coronary heart disease: prospective study and systematic review.Assessing the impact of medication use on trends in major coronary risk factors in older British men: a cohort study.Cardiovascular disease incidence and mortality in older men with diabetes and in men with coronary heart disease.Longitudinal associations between changes in physical activity and onset of type 2 diabetes in older British men: the influence of adiposityIs socioeconomic position related to the prevalence of metabolic syndrome?: influence of social class across the life course in a population-based study of older men.Changes in environmental tobacco smoke (ETS) exposure over a 20-year period: cross-sectional and longitudinal analyses.Circulating TNFalpha levels in older men and women do not show independent prospective relations with MI or stroke.Are childhood socio-economic circumstances related to coronary heart disease risk? Findings from a population-based study of older menAre social inequalities in mortality in Britain narrowing? Time trends from 1978 to 2005 in a population-based study of older menMissed opportunities for secondary prevention of cerebrovascular disease in elderly British men from 1999 to 2005: a population-based study.Extent of social inequalities in disability in the elderly: results from a population-based study of British men.The obesity paradox in men with coronary heart disease and heart failure: the role of muscle mass and leptin.High diet quality is associated with a lower risk of cardiovascular disease and all-cause mortality in older men.High prevalence of potentially virulent strains of Helicobacter pylori in the general male British population.Physical activity and hemostatic and inflammatory variables in elderly men.Inequalities in heart failure in older men: prospective associations between socioeconomic measures and heart failure incidence in a 10-year follow-up study.Longitudinal associations of socioeconomic position in childhood and adulthood with decline in lung function over 20 years: results from a population-based cohort of British men.Tissue plasminogen activator antigen and coronary heart disease. Prospective study and meta-analysis.Metabolic syndrome vs Framingham Risk Score for prediction of coronary heart disease, stroke, and type 2 diabetes mellitus.Insulin resistance, haemostatic and inflammatory markers and coronary heart disease risk factors in Type 2 diabetic men with and without coronary heart disease.Associations between cigarette smoking, pipe/cigar smoking, and smoking cessation, and haemostatic and inflammatory markers for cardiovascular disease.The metabolic syndrome and insulin resistance: relationship to haemostatic and inflammatory markers in older non-diabetic men.Social engagement and the risk of cardiovascular disease mortality: results of a prospective population-based study of older men.Tissue plasminogen activator, von Willebrand factor, and risk of type 2 diabetes in older men.Hepatic enzymes, the metabolic syndrome, and the risk of type 2 diabetes in older men.Height loss in older men: associations with total mortality and incidence of cardiovascular disease.Reasons for intentional weight loss, unintentional weight loss, and mortality in older men.
P50
Q28191878-DE34A1B6-04FE-40F1-928A-339EDF7932F3Q28755180-2342B6F4-5669-44E6-915F-BD4767D8C418Q28768056-2E5A7A78-57FF-4F31-9274-544F8103B8D6Q33337548-3B6CF233-98F1-448E-8FAC-DF20304717FEQ33606543-DA6D3997-BDE7-4CE8-9F9B-95CF5167A620Q33606548-8103CF7B-4ECF-4AE3-9BAC-562275231675Q33658683-50F5FC43-6A37-4B57-AA28-590108EC7215Q33908597-263E019D-6481-4C5B-B82D-00FA69F5FC1EQ33932688-427EF757-D5A9-4E35-B44C-30AE21573D75Q34009543-C80757E4-DDB9-4CB2-897E-D9D5BFFF30A9Q34276223-D3091D71-C5AA-4727-ADF6-3C5BBA64AA3FQ34522210-5EC100B9-987A-41BB-A989-6116DBD2913EQ34819374-9FEC9BDB-9898-477E-BECA-E18400B89F3AQ35136905-5F915654-E9C5-4EB7-8E2C-C9EF094CD945Q35356996-F180D2E3-B41E-41DE-A830-E93E661C6C02Q35583188-DA05DC1F-E10A-4571-BCA0-DB135A13636EQ36181325-8B8C3F83-B07B-4B55-857B-106052038995Q36975738-BCA59C97-8047-4039-8D3D-DA0F5C312934Q37155789-BBCB3631-7DCF-4B7D-B2F2-579DEFADF8A0Q37251850-31D4D01B-7C0B-4D49-9C7A-BD309EE23A37Q37256794-AD4B3140-E2DB-4F86-B466-392181C5A83FQ37258186-90DDD2C9-5A1B-4DC7-A43F-D6CA77BF3A00Q37297492-F75F8EC9-F10E-45E6-9249-651B343DC46AQ37308679-2D404697-974C-4A93-B73C-5EA4B40F32E3Q37539890-A99A9872-230B-47C3-91A3-888243F3892AQ37701522-C21AE257-5B14-4774-8546-0948D0B721E4Q42628374-CCB525D7-7951-4190-AC85-BE93647E20ADQ43961149-4D1F9D68-795A-4C16-A486-DAFF82A1F99EQ43983833-743370FC-D6A7-4319-849B-499E078ACCDDQ44492659-12D7D107-C69D-4D3F-AD64-3C940042A6E0Q44769672-D7D664DC-52E9-4745-8FD8-07AC0D9B9E8DQ44853673-609306EA-6742-4E56-B8DD-C6BA7DD3CDEEQ45057616-BB1BCC99-9385-4A15-A46A-BA953D864080Q46427634-E295E8D3-6EA5-4EFF-9DDB-FB36B1F936CAQ46530581-AD1C9558-B57C-445F-A5D0-E221B75C6184Q46740336-19DBB609-0F50-4252-B0B9-2F64B10CE8E7Q46782046-8AF0F58E-8739-4B91-844B-D76DE3343FB9Q46818839-F4384163-3935-45C5-9CB2-B138AC0E9D63Q47310536-FEFC098D-2E8C-442E-A520-88B8B66D495BQ47382525-40E64E98-FFF7-47FC-B980-0FB2F505AB4C
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Lucy T. Lennon
@ast
Lucy T. Lennon
@en
Lucy T. Lennon
@es
Lucy T. Lennon
@nl
Lucy T. Lennon
@sl
type
label
Lucy T. Lennon
@ast
Lucy T. Lennon
@en
Lucy T. Lennon
@es
Lucy T. Lennon
@nl
Lucy T. Lennon
@sl
prefLabel
Lucy T. Lennon
@ast
Lucy T. Lennon
@en
Lucy T. Lennon
@es
Lucy T. Lennon
@nl
Lucy T. Lennon
@sl
P106
P1153
6603033975
P21
P31
P496
0000-0002-1738-1351